Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study

References

• SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201473349250924161836
   PubMed Web of Science ®Google Scholar
• MachadoPCastrejonIKatchamartWMultinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeAnn Rheum Dis2011701152420724311
   PubMed Web of Science ®Google Scholar
• AbásoloLLeónLRodríguez-RodriguezLSafety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditionsSemin Arthritis Rheum201544550651325532946
   PubMed Web of Science ®Google Scholar
• SalliotCvan der HeijdeDLong-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature researchAnn Rheum Dis20096871100110419060002
   PubMed Web of Science ®Google Scholar
• KremerJMPhelpsCTLong-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 monthsArthritis Rheum19923521381451734902
   PubMed Web of Science ®Google Scholar
• VisserKvan der HeijdeDMRisk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literatureClin Exp Rheumatol20092761017102520149325
   PubMed Web of Science ®Google Scholar
• WoodrickRSRudermanEMSafety of biologic therapy in rheumatoid arthritisNat Rev Rheumatol201171163965221989284
   PubMed Web of Science ®Google Scholar
• RudermanEMOverview of safety of non-biologic and biologic DMARDsRheumatology201251SUPPL 6374322075064
   PubMed Web of Science ®Google Scholar
• Machado-AlbaJERuizAFMachado-DuqueMEAdverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritisRev Panam Salud Publica201436639640125711751
   PubMed Web of Science ®Google Scholar
• Rubbert-RothAAssessing the safety of biologic agents in patients with rheumatoid arthritisRheumatology201251suppl 5v38v4722718926
   PubMed Web of Science ®Google Scholar
• StorageSSAgrawalHFurstDEDescription of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritisKorean J Intern Med201025111720195397
   PubMedGoogle Scholar
• SakaiRChoS-KNankiTHead-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryArthritis Res Ther201517111025566937
   PubMed Web of Science ®Google Scholar
• AithalGPHepatotoxicity related to antirheumatic drugsNat Rev Rheumatol20117313915021263458
   PubMed Web of Science ®Google Scholar
• CurtisJRBeukelmanTOnofreiAElevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomideAnn Rheum Dis20106901434719147616
   PubMed Web of Science ®Google Scholar
• AnelliMGSciosciaCGrattaglianoILapadulaGOld and new antirheumatic drugs and the risk of hepatotoxicityTher Drug Monit201234662262823128910
   PubMed Web of Science ®Google Scholar
• TobonGJCañasCJallerJJRestrepoJCAnayaJMSerious liver disease induced by infliximabClin Rheumatol200726457858116547695
   PubMed Web of Science ®Google Scholar
• SokoloveJStrandVGreenbergJDRisk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritisAnn Rheum Dis20106991612161720448284
   PubMed Web of Science ®Google Scholar
• FitzmauriceGLairdNWareJApplied Longitudinal Analysis1st edHoboken, New JerseyWiley John & Sons2004
   Google Scholar
• AgrestiACategorical Data Analysis3rd edWiley John & Sons2012
   Google Scholar
• R Development Core TeamR: A language and environment for statistical computingR Foundation for Statistical ComputingVienna, Austria2017
   Google Scholar
• BatesDMächlerMBolkerBWalkerSFitting linear mixed-effects models using lme4J Stat Softw2015671148
   Web of Science ®Google Scholar
• RomãoVCLimaABernardesMCanhãoHFonsecaJEThree decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?Immunol Res2014602–328931025391609
   PubMed Web of Science ®Google Scholar
• KamedaHKanbeKSatoEContinuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR studyJ Rheumatol20113881585159221572151
   PubMed Web of Science ®Google Scholar
• KamedaHUekiYSaitoKEtanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trialMod Rheumatol201020653153820574649
   PubMed Web of Science ®Google Scholar
• EmeryPBreedveldFCHallSComparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialLancet2008372963637538218635256
   PubMed Web of Science ®Google Scholar
• GarrisonLMcdonnellNDEtanercept: therapeutic use in patients with rheumatoid arthritisAnn Rheum Dis199958Supplement 1i65i6910577976
   PubMed Web of Science ®Google Scholar
• EmeryPSebbaAHuizingaTWBiologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisAnn Rheum Dis201372121897190423918035
   PubMed Web of Science ®Google Scholar
• MikulsTRMorelandLWTNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanerceptExpert Opin Pharmacother200121758411336570
   PubMedGoogle Scholar
• MansourniaMAEtminanMDanaeiGKaufmanJSCollinsGHandling time varying confounding in observational researchBMJ201735910j458729038130
   PubMed Web of Science ®Google Scholar
• HeCFengPSuHGuAYanZZhuXDisrupted Th1/Th2 balance in patients with rheumatoid arthritis (RA)Int J Clin Exp Pathol201710212331242
   Web of Science ®Google Scholar
• HermanSZurgilNLangevitzPEhrenfeldMDeutschMMethotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patientsClin Exp Rheumatol200826231732318565255
   PubMed Web of Science ®Google Scholar